Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
27.18
-0.39 (-1.41%)
Jul 31, 2026, 4:00 PM EDT - Market closed
Tango Therapeutics Employees
Tango Therapeutics had 137 employees as of December 31, 2025. The number of employees decreased by 18 or -11.61% compared to the previous year.
Employees
137
Change (1Y)
-18
Growth (1Y)
-11.61%
Revenue / Employee
$416,000
Profits / Employee
-$782,715
Market Cap
3.93B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 137 | -18 | -11.61% |
| Dec 31, 2024 | 155 | 15 | 10.71% |
| Dec 31, 2023 | 140 | 30 | 27.27% |
| Dec 31, 2022 | 110 | 19 | 20.88% |
| Sep 30, 2022 | 109 | 26 | 31.33% |
| Jun 30, 2022 | 103 | 17 | 19.77% |
| Mar 31, 2022 | 98 | 21 | 27.27% |
| Dec 31, 2021 | 91 | 14 | 18.18% |
| Sep 30, 2021 | 83 | 6 | 7.79% |
| Jun 30, 2021 | 86 | - | - |
| Mar 31, 2021 | 77 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,965 |
| Arcus Biosciences | 601 |
| Denali Therapeutics | 507 |
| Alumis | 227 |
| Relay Therapeutics | 193 |
| Celcuity | 155 |
| Edgewise Therapeutics | 154 |
| Parabilis Medicines | 145 |
TNGX News
- 16 days ago - Tango Therapeutics price target raised to $40 from $36 at Mizuho - TheFly
- 19 days ago - Tango Therapeutics initiated with an Overweight at JPMorgan - TheFly
- 4 weeks ago - Tango Therapeutics price target raised to $46 from $42 at Canaccord - TheFly
- 5 weeks ago - Tango Therapeutics upgraded to Buy from Hold at Jefferies - TheFly
- 5 weeks ago - Tango Therapeutics Appoints Robert Azelby to Board of Directors - GlobeNewsWire
- 7 weeks ago - Tango Therapeutics 18.2M share Secondary priced at $30.00 - TheFly
- 7 weeks ago - Tango Therapeutics Announces Pricing of $600 Million Upsized Public Offering - GlobeNewsWire
- 7 weeks ago - Tango Therapeutics price target raised to $66 from $27 at H.C. Wainwright - TheFly